These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 27964704)
1. Common SAR Derived from Linear and Non-linear QSAR Studies on AChE Inhibitors used in the Treatment of Alzheimer's Disease. Pulikkal BP; Marunnan SM; Bandaru S; Yadav M; Nayarisseri A; Sureshkumar S Curr Neuropharmacol; 2017 Nov; 15(8):1093-1099. PubMed ID: 27964704 [TBL] [Abstract][Full Text] [Related]
2. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease. Gurung AB; Aguan K; Mitra S; Bhattacharjee A J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776 [TBL] [Abstract][Full Text] [Related]
3. Development of MLR and SVM Aided QSAR Models to Identify Common SAR of GABA Uptake Herbal Inhibitors used in the Treatment of Schizophrenia. Marunnan SM; Pulikkal BP; Jabamalairaj A; Bandaru S; Yadav M; Nayarisseri A; Doss VA Curr Neuropharmacol; 2017 Nov; 15(8):1085-1092. PubMed ID: 27919211 [TBL] [Abstract][Full Text] [Related]
4. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease. Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408 [TBL] [Abstract][Full Text] [Related]
5. Machine learning models for predicting the activity of AChE and BACE1 dual inhibitors for the treatment of Alzheimer's disease. Dhamodharan G; Mohan CG Mol Divers; 2022 Jun; 26(3):1501-1517. PubMed ID: 34327619 [TBL] [Abstract][Full Text] [Related]
6. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease. Son M; Park C; Rampogu S; Zeb A; Lee KW Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604 [TBL] [Abstract][Full Text] [Related]
7. QSAR studies on N-aryl derivative activity towards Alzheimer's disease. Solomon KA; Sundararajan S; Abirami V Molecules; 2009 Apr; 14(4):1448-55. PubMed ID: 19384276 [TBL] [Abstract][Full Text] [Related]
8. Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors. Deb PK; Sharma A; Piplani P; Akkinepally RR Mol Divers; 2012 Nov; 16(4):803-23. PubMed ID: 22996404 [TBL] [Abstract][Full Text] [Related]
9. Identification of promising inhibitory heterocyclic compounds against acetylcholinesterase using QSAR, ADMET, biological activity, and molecular docking. Nguyen HD; Kim MS Comput Biol Chem; 2023 Jun; 104():107872. PubMed ID: 37119698 [TBL] [Abstract][Full Text] [Related]
10. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents. Ambure P; Kar S; Roy K Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852 [TBL] [Abstract][Full Text] [Related]
11. 2D-SAR and 3D-QSAR analyses for acetylcholinesterase inhibitors. Niu B; Zhao M; Su Q; Zhang M; Lv W; Chen Q; Chen F; Chu D; Du D; Zhang Y Mol Divers; 2017 May; 21(2):413-426. PubMed ID: 28275924 [TBL] [Abstract][Full Text] [Related]
12. 3D QSAR based Virtual Screening of Flavonoids as Acetylcholinesterase Inhibitors. Andole S; Sd H; Sudhula S; Vislavath L; Boyina HK; Gangarapu K; Bakshi V; Devarakonda KP Adv Exp Med Biol; 2023; 1424():233-240. PubMed ID: 37486499 [TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors. Gharaghani S; Khayamian T; Ebrahimi M SAR QSAR Environ Res; 2013; 24(9):773-94. PubMed ID: 23863115 [TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR studies of some reversible Acetyl cholinesterase inhibitors based on CoMFA and ligand protein interaction fingerprints using PC-LS-SVM and PLS-LS-SVM. Ghafouri H; Ranjbar M; Sakhteman A Comput Biol Chem; 2017 Aug; 69():19-27. PubMed ID: 28544873 [TBL] [Abstract][Full Text] [Related]
15. 2D & 3D-QSAR Study on Novel Piperidine and Piperazine Derivatives as Acetylcholinesterase Enzyme Inhibitors. Nazari M; Tabatabai SA; Rezaee E Curr Comput Aided Drug Des; 2018; 14(4):391-397. PubMed ID: 30047333 [TBL] [Abstract][Full Text] [Related]
16. QSAR model for prediction of the therapeutic potency of N-benzylpiperidine derivatives as AChE inhibitors. Bitam S; Hamadache M; Hanini S SAR QSAR Environ Res; 2017 Jun; 28(6):471-489. PubMed ID: 28610432 [TBL] [Abstract][Full Text] [Related]
17. Genetic Algorithm and Self-Organizing Maps for QSPR Study of Some N-aryl Derivatives as Butyrylcholinesterase Inhibitors. Ahmadi S; Ganji S Curr Drug Discov Technol; 2016; 13(4):232-253. PubMed ID: 27457492 [TBL] [Abstract][Full Text] [Related]
18. Common SAR Derived from Multiple QSAR Models on Vorinostat Derivatives Targeting HDACs in Tumor Treatment. Praseetha S; Bandaru S; Yadav M; Nayarisseri A; Sureshkumar S Curr Pharm Des; 2016; 22(33):5072-5078. PubMed ID: 27339433 [TBL] [Abstract][Full Text] [Related]
19. Virtual screening, molecular interaction field, molecular dynamics, docking, density functional, and ADMET properties of novel AChE inhibitors in Alzheimer's disease. da Silva CH; Carvalho I; Taft CA J Biomol Struct Dyn; 2007 Jun; 24(6):515-24. PubMed ID: 17508773 [TBL] [Abstract][Full Text] [Related]
20. A combinatorial feature selection approach to describe the QSAR of dual site inhibitors of acetylcholinesterase. Asadabadi EB; Abdolmaleki P; Barkooie SM; Jahandideh S; Rezaei MA Comput Biol Med; 2009 Dec; 39(12):1089-95. PubMed ID: 19854437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]